Aprocitentan: The First Endothelin Receptor Antagonist for Resistant Hypertension

Authors

• T. Nguyen
• Hui Lin, Touro College of PharmacyFollow
• D. Tint
• L. Dima
• Zhe Amy Wang, Touro College of PharmacyFollow

Roles

Author

Document Type

Article

Publication Date

1-1-2025

Publication Title

American Journal of Therapeutics

DOI

10.1097/MJT.0000000000001950

Recommended Citation

Nguyen, T., Lin, H., Tint, D., Dima, L., & Wang, Z. A. (2025). Aprocitentan: The First Endothelin Receptor Antagonist for Resistant Hypertension. American Journal of Therapeutics, 32 (6), e536-e541. https://doi.org/10.1097/MJT.0000000000001950